Three materials.
Three distinct roles.
A visual comparison of RT, TRZ, and NAD+ for qualified research contexts.

RT
Studied in controlled models involving GLP-1, GIP, and glucagon receptor pathways.
- Signaling
- Metabolic models
- 20MG pictured

TRZ
Studied in experimental models involving GLP-1 and GIP receptor interactions.
- Dual receptor
- Binding activity
- 30MG pictured

NAD+
Studied in controlled models involving cellular energy metabolism, redox balance, and coenzyme-related pathways.
- Cellular energy
- Redox models
- 500MG pictured
3 Pathways

Pathway-focused research context
20MG pictured
Receptor-interaction research context
30MG pictured
Metabolism and redox research context
500MG picturedDifferent Compounds.
Different Outcomes.
These compounds each have individual pathways designed for individual results.
RT and TRZ are examined for different receptor interaction profiles.
NAD+ is studied in controlled metabolic, redox, and coenzyme-related research contexts.
Strength, purity, and intended use stay visible throughout the catalog.
Your research starts here.
Small-batch availability can change. Browse our current library, select your strength, and manage each BOGO selection in the cart.
Choose Your Vials For laboratory and research use only. Not for human consumption.

